Toxicity of local anaesthetics - Have recommended maximal doses any relevance?;Lokalanästhetikatoxizität - Relevanz empfohlener maximaldosen?

Anasthesiologie und Intensivmedizin

Volumn 48, Issue 4, 2007, Pages 182-205

  Zink, Wolfgang ^a   Graf, B M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Local anaesthetics; Maximum recommended doses; Pharmacokinetics; Toxicity

Indexed keywords

ADRENALIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHEMOGLOBIN; PRILOCAINE;

BLOOD LEVEL; DRUG ABSORPTION; DRUG METABOLISM; HUMAN; INCIDENCE; REGIONAL ANESTHESIA; REVIEW; TOXICITY;

EID: 34248211188     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Mulroy MF. Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures. Reg Anesth Pain Med 2002;27:556-561.
2. Mather LE, Copeland SE, Ladd LA. Acute toxicity of local anesthetics: underlying pharmacokinetic and pharmacodynamic concepts. Reg Anaesth Pain Med 2005;30:553-566.
3. Irita K, Kawashima Y, Morita K. Critical Incidents during regional anesthesia in Japanese Society of Anesthesiologists-certified training hospitals: an analysis of responses to the annual survey conducted between 1999 and 2002 by the Japanese Society of Anesthesiologists. Masui 2005;54:440-449.
4. Zink W, Graf BM. Toxikologie der Lokalanästhetika. Anaesthesist 2003;52:1102-1123.
5. Borgeat A, Ekatodramis G, Blumenthal S. Interscalene brachial plexus anesthesia with ropivacaine 5 mg/mL and bupivacaine 5 mg/mL: effects on electrocardiogram. Reg Anesth Pain Med 2004;29:557-563.
6. Heavner JE. Let's abandon blanket maximum recommended doses of local anesthetics. Reg Anesth Pain Med 2004;29:524.
7. Scott DB. "Maximum recommended doses" of local anaesthetic drugs. Br J Anaesth 1989;63:373-374.
8. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004;29:564-575.
9. Ostad A, Kageyama N, Moy RL. Tumescent anesthesia with a lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol Surg 1996;22:921-927.
10. Jokinen MJ. The pharmacokinetics of ropivacaine in hepatic and renal insufficiency. Best Pract Res Clin Anaesthesiol 2005;19:269-274.
11. Pere P, Salonen M, Jokinen M, et al. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesth Analg 2003;96:563-569.
12. Bachmann-Menennga B, Biscoping J, Adams HA, Menges T, Krumholz W, Hempelmann G. Die Bedeutung des Entnahmeortes bei der Bestimmung von Lokalanästhetikakonzentrationen im Plasma am Beispiel von Bupivacain 0,75%. Reg Anaesth 1990;13:16-20.
13. Rosenberg PH, Pere P, Hekali R, Tuominen M. Plasma concentrations of bupivacaine and two of its metabolites during continuous interscalene brachial plexus block. Br J Anaesth 1991;66:25-30.
14. Niesel HC. Lokalanästhetika - empfohlene Grenzdosen. Anaesthesiol Reanim 1997;22:60-62.
15. Niesel HC, Kaiser H. Grenzdosis für Lokalanästhetika. Reg Anaesth 1991;14:79-82.
16. Scott DB, Jebson PJ, Braid DP, et al. Factors affecting plasma levels of lignocaine and prilocaine. Br J Anaesth 1972;44:1040-1049.
17. Braid DP, Scott DB. The Systemic Absorption of Local Analgesic Drugs. Br J Anaesth 1965;37:394-404.
18. Decocq G, Brazier M, Hary L, et al. Serum bupivacaine concentrations and transplacental transfer following repeated epidural administrations in term parturients during labour. Fundam Clin Pharmacol 1997;11:365-370.
19. Zink W, Graf BM. Benefit-risk assessment of ropivacaine in the management of postoperative pain. Drug Saf 2004;27:1093-1114.
20. Myers RR, Heckman HM. Effects of local anesthesia on nerve blood flow: studies using lidocaine with and without epinephrine. Anesthesiology 1989;71:757-762.
21. Partridge BL. The effects of local anesthetics and epinephrine on rat sciatic nerve blood flow. Anesthesiology 1991;75:243-250.
22. Kopacz DJ, Carpenter RL, Mackey DC. Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology 1989;71:69-74.
23. Guinard JP, Carpenter RL, Morell RC. Effect of local anesthetic concentration on capillary blood flow in human skin. Reg Anesth 1992;17:317-321.
24. Lee BB, Ngan Kee WD, Plummer JL, et al. The effect of the addition of epinephrine on early systemic absorption of epidural ropivacaine in humans. Anesth Analg 2002;95:1402-1407.
25. Burm AG. Clinical pharmacokinetics of epidural and spinal anaesthesia. Clin Pharmacokinet 1989;16:283-311.
26. Mather LE, Tucker GT, Murphy TM, et al. The effects of adding adrenaline to etidocaine and lignocaine in extradural anaesthesia II: Pharmacokinetics. Br J Anaesth 1976;48:989-994.
27. Brown RS, Rhodus NL. Epinephrine and local anesthesia revisited. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:401-408.
28. Mather LE, Thomas J. Bupivacaine binding to plasma protein fractions. J Pharm Pharmacol 1978;30:653-654.
29. Groen K, Mantel M, Zeijlmans PW, et al. Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates. Anesth Analg 1998;86:361-366.
30. Kietzmann D, Foth H, Geng WP, et al. Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia. Acta Anaesthesiol Scand 1995;39:885-890.
31. Naguib M, Magboul MM, Samarkandi AH, Attia M. Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Saf 1998;18:221-250.
32. Eriksson E. Prilocaine. An experimental study in man of a new local anaesthetic with special regard to efficacy, toxicity and excretion. Acta Chir Scand Suppl 1966;358:1-82.
33. Bodenham A, Park GR. Plasma concentrations of bupivacaine after intercostal nerve block in patients after orthotopic liver transplantation. Br J Anaesth 1990;64:436-441.
34. Pere P, Tuominen M, Rosenberg PH. Cumulation of bupivacaine, desbutylbupivacaine and 4-hydroxybupivacaine during and after continuous interscalene brachial plexus block. Acta Anaesthesiol Scand 1991;35:647-650.
35. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003;55:667-686.
36. Hansen TG, Ilett KF, Reid C, et al. Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations. Anesthesiology 2001;94:579-584.
37. Bowdle TA, Freund PR. The effect of age on plasma clearance of epidural lidocaine and bupivacaine. Anesth Analg 1988;67:299.
38. Veering BT, Burm AG, Gladines MP, Spierdijk J. Age does not influence the serum protein binding of bupivacaine. Br J Clin Pharmacol 1991;32:501-503.
39. Veering BT, Burm AG, Spierdijk J. Spinal anaesthesia with hyperbaric bupivacaine. Effects of age on neural blockade and pharmacokinetics. Br J Anaesth 1988;60:187-194.
40. Jokinen MJ, Neuvonen PJ, Lindgren L, et al. Pharmacokinetics of Ropivacaine in Patients with Chronic End-stage Liver Disease. Anesthesiology 2007;106:43-55.
41. Mather LE, McCall P, McNicol PL. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth Analg 1995;80:328-335.
42. Thomson PD, Rowland M, Melmon KL. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Am Heart J 1971;82:417-421.
43. Thomson PD, Melmon KL, Richardson JA, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 1973;78:499-508.
44. Biscoping J, Kling D, von Bormann B, et al. Vergleichende Untersuchungen zur Dosisanpassung der intraoperativen Lidocain-Therapie bei herzinsuffizienten Patienten. Anaesth Intensivther Notfallmed 1985;20:136-138.
45. Bader AM, Tsen LC, Camann WR, et al. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999;90:1596-1601.
46. Butterworth JFt, Walker FO, Lysak SZ. Pregnancy increases median nerve susceptibility to lidocaine. Anesthesiology 1990;72:962-965.
47. Palkama VJ, Neuvonen PJ, Olkkola KT. Effect of itraconazole on the pharmacokinetics of bupivacaine enantiomers in healthy volunteers. Br J Anaesth 1999;83:659-661.
48. Isohanni MH, Neuvonen PJ, Palkama VJ, Olkkola KT. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine. Eur J Clin Pharmacol 1998;54:561-565.
49. Bowdle TA, Freund PR, Slattery JT. Propranolol reduces bupivacaine clearance. Anesthesiology 1987;66:36-38.
50. Burm AG, van der Meer AD, van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994;38:125-129.
51. Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine. Anesth Analg, 2000:1207-1212.
52. Jokinen MJ, Olkkola KT, Ahonen J, Neuvonen PJ. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine. Eur J Clin Pharmacol 2003;58:653-657.
53. Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. Pharmacol Toxicol 2001;88:187-191.
54. Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med 2004;29:333-340.
55. Scott DB, Owen JA, Richmond J. Methaemoglobinaemia due to prilocaine. Lancet 1964;171:728-729.
56. Fisher MA, Henry D, Gillam L, Chen C. Toxic methemoglobinemia: a rare but serious complication of transesophageal echocardiography. Can J Cardiol 1998;14:1157-1160.
57. Logan BK, Gordon AM. Death of an infant involving benzocaine. J Forensic Sci 2005;50:1486-1488.
58. Hahn IH, Hoffman RS, Nelson LS. EMLA-induced methemoglobinemia and systemic topical anesthetic toxicity. J Emerg Med 2004;26:85-88.
59. Gunter JB. Benefit and risks of local anesthetics in infants and children. Paediatr Drugs 2002;4:649-672.
60. Bowdle TA, Freund PR. Effect of age on maximum circulating local anesthetic concentrations during epidural anesthesia. Anesth Analg 1988;67:419-421.
61. Simon MJ, Veering BT, Stienstra R, et al. Effect of age on the clinical profile and systemic absorption and disposition of levobupivacaine after epidural administration. Br J Anaesth 2004;93:512-520.
62. Thomson PD. Alteration in pharmacologic response induced by cardiovascular disease. Cardiovasc Clin 1974;6:55-61.
63. Kubota Y, Toyoda Y, Kubota H, Asada A. Epinephrine in local anesthetics does indeed produce hypokalemia and ECG changes. Anesth Analg 1993;77:867-868.
64. Flanagan HL, Datta S, Lambert DH, et al. Effect of pregnancy on bupivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg 1987;66:123-126.
65. Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine. Anesth Analg 2000;91:1207-1212.
66. Mather LE, Chang DH. Cardiotoxicity with modern local anaesthetics: is there a safer choice? Drugs 2001;61:333-342.
67. Graf BM. The cardiotoxicity of local anesthetics: the place of ropivacaine. Curr Top Med Chem 2001;1:207-214.
68. Mulroy MF. Local anesthetics: helpful science, but don't forget the basic clinical safety steps. Reg Anesth Pain Med 2005:30:513-515.
69. Mulroy M, Glosten B. The epinephrine test dose in obstetrics: note the limitations. Anesth Analg 1998;86:923-925.